Table 1.
Author, year [ref.] | No. | Tracer | Analysis | MI excluded | Quality | Sens (%) | Spec (%) | Acc (%) |
---|---|---|---|---|---|---|---|---|
Tamaki, 1984 [11] | 104 | 201Tl | Q | Botha | 2 | 98 | 91 | 96 |
DePasquale, 1988 [12] | 210 | 201Tl | Q | Botha | 2 | 95 | 74 | 92 |
Fintel, 1989 [13] | 135 | 201Tl | V | No | 2 | 83 | – | – |
Iskandrian, 1989 [14] | 193 | 201Tl | V | Yes | 2 | 86 | 62 | 79 |
Maddahi, 1989 [15] | 110 | 201Tl | Q | Botha | 3 | 95 | 56 | 88 |
Mahmarian, 1990 [16] | 296 | 201Tl | Q | Botha | 3 | 87 | 87 | 87 |
Van Train, 1990 [17] | 242 | 201Tl | Q | Botha | 2 | 94 | 43 | 85 |
Coyne, 1991 [18] | 100 | 201Tl | V | No | 2 | 81 | 74 | 77 |
Quinones, 1992 [19] | 112 | 201Tl | V | Yes | 1 | 77 | 81 | 78 |
Chae, 1993 [20] | 243 | 201Tl | V | No | 3 | 71 | 63 | 69 |
Grover-McKay, 1994 [21] | 18 | 201Tl | V | No | 1 | 91 | 86 | 89 |
Tamaki, 1994 [22] | 25 | 201Tl | V | No | 1 | 95 | 33 | 88 |
Ho, 1997 [23] | 51 | 201Tl | V | Botha | 3 | 76 | 77 | 76 |
Kiat, 1990 [24] | 53 | MIBI | Q | Botha | 2 | 94 | 80 | 92 |
Pozzoli, 1991 [25] | 75 | MIBI | V | No | 1 | 84 | 88 | 85 |
Solot, 1993 [26] | 78 | MIBI | V | No | 2 | 96 | 74 | 90 |
Marwick, 1994 [27] | 86 | MIBI | V | Yes | 2 | 73 | 70 | 72 |
Van Train, 1994 [28] | 124 | MIBI | Q | Botha | 2 | 89 | 36 | 81 |
Tamaki, 1994 [22] | 26 | Tetro | V | No | 1 | 96 | 67 | 92 |
Heo, 1994 [29] | 23 | Tetro | V | No | 2 | 87 | – | – |
Benoit, 1996 [30] | 30 | Tetro | V | Yes | 2 | 81 | 89 | 83 |
Shanoudy, 1998 [31] | 26 | Tetro | V | No | 2 | 96 | – | – |
201Tl, Thallium-201 thallous chloride; MIBI, technetium-99m 2-methoxy-isobutyl-isonitrile; Tetro, technetium-99m 1,2-bis[bis(2-ethoxyethyl) phosphino] ethane; V, visual analysis; Q, quantitative analysis; MI, myocardial infarction; Sens, sensitivity; Spec, specificity; Acc, accuracy
aAccuracy reported in full group and in subset without infarction; figures in table relate to whole patient group